Antitumor cytotoxicity mediated by ligand-activated human V alpha 24 NKT cells
Authors
Kawano, T
Nakayama, T
Kamada, N
Kaneko, Y
Harada, M
Ogura, N
Akutsu, Y
Motohashi, S
Iizasa, T
Endo, H
Fujisawa, T
Shinkai, H
Taniguchi, M
Citation
T. Kawano et al., Antitumor cytotoxicity mediated by ligand-activated human V alpha 24 NKT cells, CANCER RES, 59(20), 1999, pp. 5102-5105
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
SICI code
0008-5472(19991015)59:20<5102:ACMBLH>2.0.ZU;2-W
Abstract
Human V alpha 24 NKT cells bearing an invariant V alpha 24J alpha Q antigen
receptor, the counterpart of the murine V alpha 14 NKT cells, are activate
d by the specific ligand, alpha-galactosylceramide (alpha-GalCer) in a CD1d
-dependent manner. Here, we demonstrate that the alpha-GalCer-activated V a
lpha 24 NKT cells exert a potent perforin-dependent cytotoxic activity agai
nst a wide variety of human tumor cell lines. In addition, we demonstrate t
hat V alpha 24 NKT cells and dendritic cells (DCs) from melanoma patients a
re functionally normal, even in the tumor-hearing status. The potential use
of alpha-GalCer-activated V alpha 24 NKT cells and/or DCs from patients fo
r cancer immunotherapy is discussed.